- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01226433
Family Planning Through Dairy Cooperatives
Providing Family Planning Services Sustainably Through Dairy Cooperatives in Kenya
Aperçu de l'étude
Statut
Description détaillée
Access to family planning and other reproductive health services remains difficult in much of rural Kenya. One option for improving rural access to family planning is to use existing community events outside of the health sector as platforms for delivering information and services. This study will assess a model for providing family planning through quarterly events organized by dairy cooperatives supported by Land O'Lakes in Kenya. During these events, known as Field Days, a healthcare provider will have a tent in which Field Day attendees can receive basic family health services free of charge. The services offered will be: family planning counseling and methods, immunizations, antenatal care, screening and treatment for sexually transmitted infections, and HIV counseling and testing. Since the services are no different than those that could be obtained at Ministry of Health or some private facilities, the service provision is not considered to be part of the research.
Women receiving any service from the health care provider will be recruited for an interview that will measure their demand for family planning and attitudes about receiving services during the field day. In addition, the study will track the number of different types of services provided, the total number of Field Day attendees, and the cost of the service model. The study will be carried out at five Field Days in Rift Valley and Central provinces.
Participants will not be tested for STI/HIV as part of this research; however, at their request, they may have received a test from the provider prior to the research interview. At the time of consent, they will have already received the test, so the consent form will not include anything specific to testing. In Kenya, all STI/HIV test results are reported to the national public health authorities. These reports are not used for contacting patients but for planning purposes.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Rift Valley & Central
-
Various, Rift Valley & Central, Kenya
- 5 Community Outreach Events
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:females aged 18-49 receiving health services at a field day event -
Exclusion Criteria:
-
Plan d'étude
Comment l'étude est-elle conçue ?
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Health Services Research
Délai: 1 year
|
Unmet need for family planning among women attending Field Days aged 18-49
|
1 year
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Health Services Research
Délai: 1 year
|
Interest in receiving health services through Field Day model
|
1 year
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: John Bratt, MPP, MA, FHI 360
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
- Événement indésirable EI
- Syndrome d'immunodéficience acquise du SIDA
- ALT (SGPT) alanine aminotransférase
- ART thérapie antirétrovirale
- AST (SGOT) aspartate aminotransférase
- Formulaires de collecte de données DCF
- Comité de surveillance des données DMC
- FDA (États-Unis) Food and Drug Administration
- Lignes directrices sur les bonnes pratiques cliniques GCP
- HB sAg Antigène de surface de l'hépatite B
- Conférence internationale d'harmonisation de l'ICH
- IND Demande de nouveau médicament expérimental
- Comité d'examen institutionnel de la CISR
- Unités internationales UI
- mg milligramme(s)
- mm3 millimètre cube(s)
- Réaction en chaîne par polymérase PCR
- Événement indésirable grave SAE
- µg microgramme
- LSN limite supérieure de la plage normale
- WB Western Blot
Autres numéros d'identification d'étude
- 10227
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .